Zoetis Inc (ZTS)
167.07
-0.16
(-0.10%)
USD |
NYSE |
May 03, 16:00
167.02
-0.06
(-0.03%)
After-Hours: 20:00
Zoetis Cash from Investing (Quarterly): -131.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -131.00M |
| December 31, 2023 | -210.00M |
| September 30, 2023 | -271.00M |
| June 30, 2023 | -80.00M |
| March 31, 2023 | -216.00M |
| December 31, 2022 | -438.00M |
| September 30, 2022 | -124.00M |
| June 30, 2022 | -203.00M |
| March 31, 2022 | -118.00M |
| December 31, 2021 | -142.00M |
| September 30, 2021 | -114.00M |
| June 30, 2021 | -139.00M |
| March 31, 2021 | -63.00M |
| December 31, 2020 | -177.00M |
| September 30, 2020 | -174.00M |
| June 30, 2020 | -164.00M |
| March 31, 2020 | -57.00M |
| December 31, 2019 | -213.00M |
| September 30, 2019 | -209.00M |
| June 30, 2019 | -59.00M |
| March 31, 2019 | -23.00M |
| December 31, 2018 | -74.00M |
| September 30, 2018 | -2.064B |
| June 30, 2018 | -76.00M |
| March 31, 2018 | -45.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -54.00M |
| September 30, 2017 | -128.00M |
| June 30, 2017 | -40.00M |
| March 31, 2017 | -48.00M |
| December 31, 2016 | -59.00M |
| September 30, 2016 | -124.00M |
| June 30, 2016 | -49.00M |
| March 31, 2016 | 18.00M |
| December 31, 2015 | -737.00M |
| September 30, 2015 | -60.00M |
| June 30, 2015 | -44.00M |
| March 31, 2015 | -274.00M |
| December 31, 2014 | -50.00M |
| September 30, 2014 | -42.00M |
| June 30, 2014 | -50.00M |
| March 31, 2014 | -45.00M |
| December 31, 2013 | -51.00M |
| September 30, 2013 | -54.00M |
| June 30, 2013 | -52.00M |
| March 31, 2013 | -22.00M |
| December 31, 2012 | -46.00M |
| September 30, 2012 | -30.00M |
| June 30, 2012 | -26.00M |
| March 31, 2012 | -33.00M |
| December 31, 2011 | -26.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-438.00M
Minimum
Dec 2022
-57.00M
Maximum
Mar 2020
-165.10M
Average
-153.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -66.00M |
| Pfizer Inc | -11.00B |
| Eli Lilly and Co | -1.178B |
| Bristol-Myers Squibb Co | -19.62B |
| Amgen Inc | -217.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 595.00M |
| Cash from Financing (Quarterly) | -524.00M |
| Free Cash Flow | 1.75B |
| Free Cash Flow Per Share (Quarterly) | 0.9917 |
| Free Cash Flow to Equity (Quarterly) | 436.00M |
| Free Cash Flow to Firm (Quarterly) | 475.85M |
| Free Cash Flow Yield | 2.27% |